Newborns should be careful of side effects when taking Yinzhihuang oral solution

Newborns will inevitably have some gastrointestinal diseases after birth, so they need to be treated with medication. Medication for newborns must be taken under the guidance of a doctor. Yinzhihuang oral liquid is a common oral liquid that can clear away heat and detoxify, remove jaundice, and treat acute hepatitis and severe hepatitis. However, Yinzhihuang oral liquid is a medicine after all. The dosage and usage for newborns and the side effects after taking it should be based on the child's physical condition and the doctor's guidance.

application

[Usage and Dosage] Oral, 10 ml at a time, 3 times a day.

[Properties] This product is a brown-red liquid; it tastes sweet and slightly bitter.

[Specification] Each bottle 10ml (containing baicalin 0.4g)

[Storage] Sealed and stored in a cool place.

【Key words】 Clearing away heat, detoxifying, removing dampness, removing jaundice, reducing jaundice, lowering alanine aminotransferase, acute hepatitis, chronic hepatitis, severe hepatitis

Disclaimer: The above content is for reference only. The actual situation is subject to the hospital diagnosis and doctor's advice.

Identification

(1) Take the solution under [Content Determination] and measure it by spectrophotometry (Appendix V). Maximum absorption should be found at wavelengths of 276±2nm and 317±2nm.

(2) Take 10 ml of this product, add 1 ml of dilute hydrochloric acid, heat to about 80°C, cool, filter, transfer the filtrate to a separatory funnel, add ethyl acetate to extract twice, 10 ml each time, combine the ethyl acetate solutions, evaporate to dryness, add 2 ml of ethanol to dissolve the residue, and use this as the test solution. Take another 3g of Artemisia capillaris reference medicinal material, add 50ml of water, boil for 5-10 minutes, cool, filter, add 10ml of ethyl acetate to the filtrate, and prepare the reference medicinal material solution in the same way. According to the thin layer chromatography method (Appendix ⅥB), 2 μl of the test sample solution and 5 μl of the control drug solution were respectively spotted on the same silica gel G thin layer plate, and petroleum ether (60-90°C)-ethyl acetate-acetone (5:3:2) was used as the developing agent. The plate was developed, taken out, dried, sprayed with 5% potassium hydroxide ethanol solution, and examined under ultraviolet light (365nm). In the chromatogram of the test sample, the same blue fluorescent spot appears at the corresponding position in the chromatogram of the control medicinal material.

(3) Take the Gardenia jasminoides reference substance and add ethanol to prepare a solution containing 2 mg per 1 ml, which is used as the reference substance solution. According to the thin layer chromatography method (Appendix ⅥB), 3 μl of the test solution under [Identification] (2) and the above-mentioned reference solution are respectively spotted on the same silica gel G thin layer plate, and ethyl acetate-formic acid-water (10:2:1) is used as the developing solvent. The plate is developed, removed, dried, sprayed with 5% vanillin sulfuric acid solution, and blown with hot air until the spots are clearly colored. In the test sample chromatogram, a spot of the same color appears at the corresponding position in the reference sample chromatogram.